We envision a future where routine preventative care includes a blood test for cancer, just as patients are now routinely tested for early stages of heart disease. We know that if cancer is caught early enough, it often can be cured.
Thrive Launches with $110 Million Series A Financing to Integrate Earlier Detection of Multiple Cancer Types into Routine Medical Care
A cancer diagnosis is something no one wants to hear. Today, it is often detected late, once it has spread and treatment options are often limited.
At Thrive Earlier Detection, our goal is to transform this outlook: to catch cancer earlier, when it can be more effectively treated.
We are developing CancerSEEK,
a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages.
Our approach goes beyond a cancer diagnosis.
We are developing a platform that will serve as a resource to help patients and their families maneuver the often confusing and overwhelming path that follows a cancer diagnosis.